Fair Value of Financial Instruments (Tables)

12 Months Ended

Dec. 31, 2024

Fair Value Disclosures [Abstract]

Schedule of liabilities at fair value on a recurring basis

The following tables present information about the Company’s liabilities that are measured at fair value on a recurring basis as of December 31, 2024 and 2023 and indicate the fair value hierarchy level of the valuation techniques and inputs that the Company utilized to determine such fair value:

December 31, 2024	Quoted Prices in Active Markets		Significant Other Observable Input		Significant Other Unobservable Inputs
	(Level 1)		(Level 2)		(Level 3)
	(in thousands)
Liabilities
Public Warrants	$	1,728	$	—	$	—
Private Placement Warrants - Issued October 2019	—		—		713
Private Placement Warrants - Issued March 2023	—		—		13,820
Sponsor Shares	—		—		1,703
	$	1,728	$	—	$	16,236

December 31, 2023	Quoted Prices in Active Markets		Significant Other Observable Input		Significant Other Unobservable Inputs
	(Level 1)		(Level 2)		(Level 3)
	(in thousands)
Liabilities
Public Warrants	$	795	$	—	$	—
Private Placement Warrants - Issued October 2019	—		—		583
Private Placement Warrants - Issued March 2023	—		—		12,467
Sponsor Shares	—		—		1,304
	$	795	$	—	$	14,354

Schedule of change sin the fair value of Level 3 liabilities

The following is a summary of changes in the fair value of the Level 3 liabilities during the year ended December 31, 2024:

	Sponsor Shares		Private Placement Warrants - Issued October 2019		Private Placement Warrants - Issued March 2023
	(in thousands)
Balance as of January 1, 2024	$	1,304	$	583	$	12,467
Loss from changes in fair value	399		130		1,353
Balance as of December 31, 2024	$	1,703	$	713	$	13,820